Why the study?
Does rizatriptan trigger Takotsubo syndrome in patients with migraine?
Does rizatriptan trigger Takotsubo syndrome in patients with migraine?
Rizatriptan use for acute migraine may act as a pharmacologic trigger for Takotsubo syndrome.
Rizatriptan may trigger Takotsubo syndrome; this single case leaves open any causal link and should not change practice.
Background: Takotsubo syndrome (TS) is a clinical condition mimicking acute coronary syndrome characterized by reversible acute systolic dysfunction. TS is typically associated with a catecholaminergic surge resulting from physical or emotional stress while some pharmacologic agents may act as a trigger. Case summary: Here, we report a case of TS secondary to rizatriptan, used for treatment of acute migraine. A 67-year-old woman with a history of dyslipidemia, type II diabetes, and migraine was admitted with chest heaviness shortly after taking rizatriptan for migraine. Deepening T wave inversion was seen in multiple territories on electrocardiogram and hs-troponin T was elevated. Cardiac imaging including echocardiogram coronary angiography and cardiac magnetic resonance imaging was consistent with a diagnosis of TS. Discussion: In this case, there was no emotional trigger for TS described. Given the compelling temporal correlation between the onset of typical chest pain and medication use, a diagnosis of TS secondary to rizatriptan was made.
No takes yet. Share an insight, caveat, or question.
Somers‐Edgar et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: